EA200801408A1 - Способы и композиции, применяемые при лечении расстройств желудочно-кишечного тракта - Google Patents

Способы и композиции, применяемые при лечении расстройств желудочно-кишечного тракта

Info

Publication number
EA200801408A1
EA200801408A1 EA200801408A EA200801408A EA200801408A1 EA 200801408 A1 EA200801408 A1 EA 200801408A1 EA 200801408 A EA200801408 A EA 200801408A EA 200801408 A EA200801408 A EA 200801408A EA 200801408 A1 EA200801408 A1 EA 200801408A1
Authority
EA
Eurasian Patent Office
Prior art keywords
gastrointestinal tract
methods
disorders
diseases
treatment
Prior art date
Application number
EA200801408A
Other languages
English (en)
Russian (ru)
Inventor
Марк Дж. Карри
Original Assignee
Айронвуд Фармасьютикалз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Айронвуд Фармасьютикалз, Инк. filed Critical Айронвуд Фармасьютикалз, Инк.
Publication of EA200801408A1 publication Critical patent/EA200801408A1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A61K31/708Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/664Amides of phosphorus acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
EA200801408A 2005-11-23 2006-11-22 Способы и композиции, применяемые при лечении расстройств желудочно-кишечного тракта EA200801408A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73949105P 2005-11-23 2005-11-23
PCT/US2006/045289 WO2007062168A2 (en) 2005-11-23 2006-11-22 Methods and compositions for the treatment of gastrointestinal disorders

Publications (1)

Publication Number Publication Date
EA200801408A1 true EA200801408A1 (ru) 2008-12-30

Family

ID=38067930

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200801408A EA200801408A1 (ru) 2005-11-23 2006-11-22 Способы и композиции, применяемые при лечении расстройств желудочно-кишечного тракта

Country Status (15)

Country Link
US (2) US20090233882A1 (enExample)
EP (1) EP1957509A4 (enExample)
JP (1) JP2009517391A (enExample)
KR (1) KR20080071193A (enExample)
CN (2) CN102342953A (enExample)
AU (1) AU2006318429A1 (enExample)
BR (1) BRPI0618859A2 (enExample)
CA (1) CA2630241A1 (enExample)
EA (1) EA200801408A1 (enExample)
IL (1) IL191537A0 (enExample)
MX (1) MX2008006550A (enExample)
NO (1) NO20082758L (enExample)
NZ (1) NZ568400A (enExample)
WO (1) WO2007062168A2 (enExample)
ZA (1) ZA200804500B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10543207B2 (en) 2008-12-31 2020-01-28 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
KR101380836B1 (ko) * 2011-01-18 2014-04-09 한국기계연구원 상온진공과립분사 공정을 위한 취성재료 과립 및 이를 이용한 코팅층의 형성방법
WO2012099350A2 (ko) * 2011-01-18 2012-07-26 한국기계연구원 상온진공과립분사 공정을 위한 취성재료 과립 및 이를 이용한 코팅층의 형성방법
TWI614017B (zh) * 2012-12-21 2018-02-11 財團法人國家衛生研究院 包含中孔洞矽奈米粒子之組成物的用途
US11331279B2 (en) 2014-05-29 2022-05-17 Radius Pharmaceuticals, Inc. Stable cannabinoid formulations
US11911361B2 (en) 2014-05-29 2024-02-27 Radius Pharmaceuticals, Inc. Stable cannabinoid formulations
WO2018010965A1 (en) 2016-07-11 2018-01-18 Biolog Life Science Institute Forschungslabor Und Biochemica-Vertrieb Gmbh New equatorially modified polymer linked multimers of guanosine-3', 5'-cyclic monophosphates
EP3615079B1 (en) * 2017-04-27 2025-02-12 Fresh Cut Development, LLC Stable cannabinoid formulations
KR102049881B1 (ko) * 2018-07-16 2019-11-28 충북대학교 산학협력단 파인애플박 및 페퍼민트 에센셜 오일을 유효성분으로 포함하는 돼지의 위궤양 개선 또는 예방용 사료첨가제 조성물
CN111803484B (zh) * 2020-09-04 2021-08-17 郑州大学 奥替溴铵在制备抗肿瘤药物中的应用
KR102563307B1 (ko) * 2020-11-27 2023-08-03 한국생명공학연구원 dcGMP를 유효성분으로 포함하는 면역 증강용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2007350A6 (es) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
JPH11505258A (ja) * 1995-05-17 1999-05-18 セダーシナイ メディカル センター 小腸における消化および吸収を改善させる脂肪酸を含む組成物
US20040192638A1 (en) * 2001-07-02 2004-09-30 Oaks John A. Method and composition for prolonging the residence time of drugs in the gut
US7304036B2 (en) * 2003-01-28 2007-12-04 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US20080025966A1 (en) * 2004-01-30 2008-01-31 Currie Mark G Methods And Compositions For The Treatment Of Gastrointestinal disorders

Also Published As

Publication number Publication date
KR20080071193A (ko) 2008-08-01
EP1957509A2 (en) 2008-08-20
AU2006318429A1 (en) 2007-05-31
CN102342953A (zh) 2012-02-08
JP2009517391A (ja) 2009-04-30
WO2007062168A3 (en) 2007-12-06
MX2008006550A (es) 2008-09-23
US20120172325A1 (en) 2012-07-05
CN101360756A (zh) 2009-02-04
IL191537A0 (en) 2008-12-29
NO20082758L (enExample) 2008-08-22
BRPI0618859A2 (pt) 2011-09-13
NZ568400A (en) 2011-11-25
WO2007062168A2 (en) 2007-05-31
CA2630241A1 (en) 2007-05-31
US20090233882A1 (en) 2009-09-17
ZA200804500B (en) 2009-08-26
EP1957509A4 (en) 2010-10-27

Similar Documents

Publication Publication Date Title
NO20082758L (enExample)
NO20064121L (no) Fremgangsmate og sammensetninger for behandling av gastrointestinale forstyrrelser
WO2009064458A3 (en) Compositions for the treatment of inflammation of the gastrointestinal tract
NO20053864L (no) Fremgangsmater og blandinger for behandling av gastrointestinale forstyrrelser.
CY1112321T1 (el) Ενωσεις βενζιμιδαζολονης οι οποιες εχουν αγωνιστικη δραστικοτητα υποδοχεων 5-ητ4
WO2007022531A3 (en) Methods and compositions for the treatment of gastrointestinal disorders
DK1644021T3 (da) Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme
NO20083562L (no) Cannabinoidreseptormodulatorer
EA201000050A1 (ru) Замещенные бициклолактамные соединения
EA201290799A1 (ru) Лечение желудочно-кишечных расстройств
WO2005072113A3 (en) Compositions and methods of treatment for inflammatory diseases
RU2600790C3 (ru) Гипертонический раствор и способ очищения толстой кишки млекопитающего
ATE512969T1 (de) Benzimidazolderivate als selektive säurepumpenhemmer
NO20085051L (no) Behandling av gastrointestinale forstyrrelser med CGRP-antagonister
NO20082747L (no) Arylisoksazol-4-yl-imidazolderivater
WO2011071927A3 (en) Treatments for gastrointestinal disorders
NO20092092L (no) Arylsulfamidderivater og fremgangsmater for anvendelse derav
EA201100565A1 (ru) Композиции и способы лечения заболеваний кишечника с использованием гранулированного мезаламина
WO2005074575A3 (en) Methods and compositions for the treatment of gastrointestinal disorders
WO2006102069A3 (en) Methods and compositions for the treatment of hypertension and gastrointestinal disorders
EP1933854A4 (en) TREATMENT OF INFLAMMATORY ENDURANCE
NO20090646L (no) Xinafoatsalt av en substituert 5-oksazol-2-yl-kinolinforbindelse
NO20072764L (no) Kromanderivater som er nyttige syrepumpeantagonister
WO2007019888A3 (en) Therapeutic compositions containing mesalamine and a co-agent for treating colon diseases
PL1706383T3 (pl) Sól aminowa pochodnej karbostyrylowej użyteczna do leczenia między innymi wrzodu żołądka